Data Foundry

Drug recalls 2025

Neupogen — Class II drug recall D-0285-2025

Ongoing recall by Amgen, Inc., reported 2025-03-26, distributed nationwide. Stability data does not support expiry: the products have the potential to be out of specification at the time

Recall numberD-0285-2025
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmAmgen, Inc., Thousand Oaks, CA, United States
Recall initiated2025-02-27
Classified2025-03-18
Reported by FDA2025-03-26
DistributedNationwide (US)
Countries outside the USBE, BR, CA, CH, CL, CO, DE, DK, ES, FI, FR, GB, HK, IE, IL, IT, LU, MY, NL, PH, PL, SA, SE
Quantity313,620 vials
Reason classesspecification failure
NDC55513-0209, 55513-0209-01, 55513-0209-10, 55513-0209-20, 55513-0209-91, 55513-0530, 55513-0530-01, 55513-0530-10, 55513-0530-20, 55513-0546, 55513-0546-01, 55513-0546-10, 55513-0546-20, 55513-0924, 55513-0924-01, 55513-0924-10, 55513-0924-20, 55513-0924-91
Lot numbers1147300, 1147300A, 1152064, 1154734, 1156806, 1159109, 1163909, 1164631, 1171366, 1176114, 1182094, 1182097
Expiration dates2025-02-28, 2025-03-31, 2025-08-31, 2025-10-31, 2026-02-28, 2026-05-31, 2026-08-31, 2027-02-28, 2027-07-31

Product

Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile Solution - No Preservative, Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-530-01 (vial), NDC 55513-530-10 (box).

Reason for recall

Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0285-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.